| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81927-111-06 | 81927-111 | HUMAN PRESCRIPTION DRUG | nelarabine | nelarabine | INJECTION | INTRAVENOUS | 20230315 | N/A | ANDA | ANDA214809 | Shorla Oncology Inc. | NELARABINE | 5 mg/mL | 6 VIAL, SINGLE-DOSE in 1 CARTON (81927-111-06) / 50 mL in 1 VIAL, SINGLE-DOSE |
| 81927-111-01 | 81927-111 | HUMAN PRESCRIPTION DRUG | nelarabine | nelarabine | INJECTION | INTRAVENOUS | 20230315 | N/A | ANDA | ANDA214809 | Shorla Oncology Inc. | NELARABINE | 5 mg/mL | 1 VIAL, SINGLE-DOSE in 1 CARTON (81927-111-01) / 50 mL in 1 VIAL, SINGLE-DOSE |
| 80978-111-06 | 80978-111 | HUMAN PRESCRIPTION DRUG | NELARABINE | nelarabine injection | INJECTION | INTRAVENOUS | 20230412 | N/A | ANDA | ANDA214809 | AqVida GmbH | NELARABINE | 250 mg/50mL | 6 BOTTLE in 1 CARTON (80978-111-06) / 50 mL in 1 BOTTLE (80978-111-01) |